Table Info

Table 1.

Reasons for intradialytic hypertension phenomenon in hemodialysis patients

List of reasons
paradoxical response to the dialysis procedure
hemodynamic imbalance
older age
lower body weight
lower serum creatinine and albumin
utilization of more antihypertensive medications
history of hypertension
the removal of antihypertensive medications during hemodialysis treatment
positive sodium balance
volume overload
activation of the renin-angiotensin aldosterone and sympathetic nervous system
endothelial cell dysfunction
erythropoiesis stimulating agents
bone disease disorders
the loss of residual renal function
inflammation/oxidative stress condition
uncontrolled metabolic acidosis
big dialysis vintage
Non-adherence to some dietary and fluids restrictions
medications non-adherence

Declarations

Author contributions

VR: Writing—original draft, Data curation. SG: Conceptualization, Writing—review & editing, Visualization.

Conflicts of interest

The authors declare no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Multiple Cause of Death, 1999-2020 [Internet]. U.S. Department of Health & Human Services; [cited 2024 July 24]. Available from: https://wonder.cdc.gov/wonder/help/mcd.html

First WHO report details devastating impact of hypertension and ways to stop it [Internet]. World Health Organization; [cited 2024 July 24]. Available from: https://www.who.int/thailand/news/detail/19-09-2023-first-who-report-details-devastating-impact-of-hypertension-and-ways-to-stop-it

High Blood Pressure Facts [Internet]. U.S. Centers for Disease Control and Prevention; [cited 2024 April 26]. Available from: https://www.cdc.gov/high-blood-pressure/data-research/facts-stats/index.html

Carey RM, Whelton PK; 2017 ACC/AHA Hypertension Guideline Writing Committee. Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Ann Intern Med. 2018;168:351–8. [DOI] [PubMed]

Benetos A, Petrovic M, Strandberg T. Hypertension Management in Older and Frail Older Patients. Circ Res. 2019;124:1045–60. [DOI] [PubMed]

Oliveros E, Patel H, Kyung S, Fugar S, Goldberg A, Madan N, et al. Hypertension in older adults: Assessment, management, and challenges. Clin Cardiol. 2020;43:99–107. [DOI] [PubMed] [PMC]

Raikou VD, Kyriaki D. The Association between Intradialytic Hypertension and Metabolic Disorders in End Stage Renal Disease. Int J Hypertens. 2018;2018:1681056. [DOI] [PubMed] [PMC]

Nitta K, Okada K, Yanai M, Takahashi S. Aging and chronic kidney disease. Kidney Blood Press Res. 2013;38:109–20. [DOI] [PubMed]

Alani H, Tamimi A, Tamimi N. Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol. 2014;3:156–68. [DOI] [PubMed] [PMC]

10.

Burnier M, Egan BM. Adherence in Hypertension. Circ Res. 2019;124:1124–40. [DOI] [PubMed]

11.

Brinker S, Pandey A, Ayers C, Price A, Raheja P, Arbique D, et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J Am Coll Cardiol. 2014;63:834–5. [DOI] [PubMed] [PMC]

12.

Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J. Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis. Hypertension. 2021;77:692–705. [DOI] [PubMed]

13.

Gupta P, Patel P, Štrauch B, Lai FY, Akbarov A, Marešová V, et al. Risk Factors for Nonadherence to Antihypertensive Treatment. Hypertension. 2017;69:1113–20. [DOI] [PubMed]

14.

Burnier M, Polychronopoulou E, Wuerzner G. Hypertension and Drug Adherence in the Elderly. Front Cardiovasc Med. 2020;7:49. [DOI] [PubMed] [PMC]

15.

Schmid H, Hartmann B, Schiffl H. Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature. Eur J Med Res. 2009;14:185–90. [DOI] [PubMed] [PMC]

16.

Seng JJB, Tan JY, Yeam CT, Htay H, Foo WYM. Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature. Int Urol Nephrol. 2020;52:903–16. [DOI] [PubMed]

17.

Buren PNV. Pathophysiology and implications of intradialytic hypertension. Curr Opin Nephrol Hypertens. 2017;26:303–10. [DOI] [PubMed] [PMC]

18.

Piña IL, Di Palo KE, Brown MT, Choudhry NK, Cvengros J, Whalen D, et al. Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association. Prog Cardiovasc Dis. 2021;64:111–20. [DOI] [PubMed]

19.

Naderifar M, Tafreshi MZ, Ilkhani M, Akbarizadeh MR, Ghaljaei F. Correlation between quality of life and adherence to treatment in hemodialysis patients. J Renal Inj Prev. 2019;8:22–7. [DOI]

20.

Demir G, Efil S. Adherence to the treatment and nursing in view of individuals receiving hemodialysis treatment. Proceedings of the 2. International Antalya Scientific Research and Innovative Studies Congress;2022 March 17–21; Antalya, Turkey. 2022. pp. 292–8.

21.

Oliveira J, Sousa H, Bártolo A, Figueiredo D, Ribeiro O. Illness perception and treatment adherence in haemodialysis: a systematic review. Psychol Health Med. 2023;28:1641–55. [DOI] [PubMed]

22.

Fissell RB, Karaboyas A, Bieber BA, Sen A, Li Y, Lopes AA, et al. Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS. Hemodial Int. 2016;20:38–49. [DOI] [PubMed] [PMC]

23.

Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA. 2015;313:837–46. [DOI] [PubMed] [PMC]

24.

Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, Tanaka H, et al. Hypertension and hyperglycemia and the combination thereof enhances the incidence of chronic kidney disease (CKD) in middle-aged and older males. Clin Exp Hypertens. 2017;39:645–54. [DOI] [PubMed]

25.

Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116:991–1006. [DOI] [PubMed] [PMC]

26.

Bakris GL, Burkart JM, Weinhandl ED, McCullough PA, Kraus MA. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use. Am J Kidney Dis. 2016;68:S15–23. [DOI] [PubMed]

27.

Kheder-Elfekih R, Yannoutsos A, Blacher J, London GM, Safar ME. Hypertension and chronic kidney disease: respective contribution of mean and pulse pressure and arterial stiffness. J Hypertens. 2015;33:2010–5. [DOI] [PubMed]

28.

Zheng D, Cheng L, Zhuang Z, Gu Y, Tang L, Wang T. Correlation between pulse wave velocity and fluid distribution in hemodialysis patients. Blood Purif. 2009;27:248–52. [DOI] [PubMed]

29.

Raikou VD, Tentolouris N, Kyriaki D, Evaggelatou A, Tzanatou H. β2-Microglobulin, pulse pressure and metabolic alterations in hemodialysis patients. Nephron Clin Pract. 2011;117:c237–45. [DOI] [PubMed]

30.

Buren PNV, Inrig JK. Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension. Semin Dial. 2017;30:545–52. [DOI] [PubMed] [PMC]

31.

Agarwal R, Light RP. Intradialytic hypertension is a marker of volume excess. Nephrol Dial Transplant. 2010;25:3355–61. [DOI] [PubMed] [PMC]

32.

Flythe JE, Kunaparaju S, Dinesh K, Cape K, Feldman HI, Brunelli SM. Factors associated with intradialytic systolic blood pressure variability. Am J Kidney Dis. 2012;59:409–18. [DOI] [PubMed]

33.

Raikou VD, Kardalinos V, Kyriaki D. The Relationship of Residual Renal Function with Cardiovascular Morbidity in Hemodialysis Patients and the Potential Role of Monocyte Chemoattractant Protein-1. Kidney Dis (Basel). 2018;4:20–8. [DOI] [PubMed] [PMC]

34.

Temmar M, Liabeuf S, Renard C, Czernichow S, Esper NE, Shahapuni I, et al. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens. 2010;28:163–9. [DOI] [PubMed]

35.

Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26:155–9. [DOI] [PubMed] [PMC]

36.

Mason NA. Polypharmacy and medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011;20:492–7. [DOI] [PubMed]

37.

Lea-Henry TN, Carland JE, Stocker SL, Sevastos J, Roberts DM. Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles. Clin J Am Soc Nephrol. 2018;13:1085–95. [DOI] [PubMed] [PMC]

38.

Pazirofteh S, Rasoli J, Habibzade H, Alilu L. The effect of an educational program based on the teach-back method on adherence to diet and fluid restriction in hemodialysis patients referring to the educational-treatment centers of Urmia Medical Science University in 2020. Nursing Midwifery J. 2021;19:87–96. Perisan.

39.

Malini H, Forwaty E, Cleary M, Visentin D, Oktarina E, Lenggogeni DP. The Effect of Intradialytic Range of Motion Exercise on Dialysis Adequacy and Fatigue in Hemodialysis Patients. J Nurs Res. 2022;30:e221. [DOI] [PubMed]

40.

Umeukeje EM, Mixon AS, Cavanaugh KL. Phosphate-control adherence in hemodialysis patients: current perspectives. Patient Prefer Adherence. 2018;12:1175–91. [DOI] [PubMed] [PMC]

41.

Motonishi S, Tanaka K, Ozawa T. Iron deficiency associates with deterioration in several symptoms independently from hemoglobin level among chronic hemodialysis patients. PLoS One. 2018;13:e0201662. [DOI] [PubMed] [PMC]

42.

Rahdar Z, Jahantigh Haghighi M, Mansouri A, Siasary A, Alahyari J, et al. Probing the Relationship Between Treatment Regimen Compliance and the Quality of Life in Hemodialysis Patients: A Descriptive-Analytic Study. Med Surg Nurs J. 2019;8:e95599. [DOI]

43.

Nugroho FA, Rahmawati DA, Rahmadhani HTY. Adherence to Fluid Restriction and Quality of Life in Patients with Chronic Kidney Failure. Proceedings of the 2nd Borobudur International Symposium on Humanities and Social Sciences, BIS-HSS 2020; 2020 Novem 18; Magelang, Indonesia. 2020. [DOI]

44.

Liu MW, Syukri M, Abdullah A, Chien L. Missing In-Center Hemodialysis Sessions among Patients with End Stage Renal Disease in Banda Aceh, Indonesia. Int J Environ Res Public Health. 2021;18:9215. [DOI] [PubMed] [PMC]

45.

Putri NS, Sukartini T, Efendy F. Fluid adherence level among patients undergoing with hemodialysis. Int J Nurs Health Serv. 2019;2:320–5.

46.

Ozkan I, Taylan S. Diet and fluid restriction experiences of patients on hemodialysis: A meta-synthesis study. Rev Nefrol Dial Traspl. 2022;42:22–40.

47.

Colombijn JMT, Vonk S, Cornelis T, Boorsma S, Krekels MME, Abrahams AC, et al. Impact of phosphate binders on quality of life in dialysis patients: Results from the prospective Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes study. Nephrology (Carlton). 2022;27:834–44. [DOI] [PubMed] [PMC]

48.

Marshall MR, Curd S, Kennedy J, Khatri D, Lee S, Pireva K, et al. Structural Equation Modelling to Identify Psychometric Determinants of Medication Adherence in a Survey of Kidney Dialysis Patients. Patient Prefer Adherence. 2024;18:855–78. [DOI] [PubMed] [PMC]

49.

Tesfaye W, Parrish N, Sud K, Grandinetti A, Castelino R. Medication Adherence Among Patients With Kidney Disease: An Umbrella Review. Adv Kidney Dis Health. 2024;31:68–83. [DOI] [PubMed]